Act S.94 in conjunction with 30 and 31 Settlement Committee Meeting No. 6/2023 Settlement Committee Order No. 4/2023 Dated 21/06/2023

securities in the category of promissory note without approval from the SEC Office which is in breach of the Securities and Exchange Act B.E. 2535. SEC Act S.33 Settlement Committee Meeting No. 6/2023

conjunction with 33 Settlement Committee Meeting No. 6/2023 Settlement Committee Order No. 58/2023 Dated 21/06/2023

the approval from the SEC Office which is in breach of the Securities and Exchange Act B.E. 2535. SEC Act S.33 Settlement Committee Meeting No. 7/2023 Settlement Committee Order No. 65/2023 Dated 09

instruction or the failure to give instruction which is a duty required to be performed. SEC Act S.33 Settlement Committee Meeting No. 7/2023 Settlement Committee Order No. 66/2023 Dated 09/08/2023

required to be performed. SEC Act S.300 in conjunction with 33 Settlement Committee Meeting No. 7/2023 Settlement Committee Order No. 67/2023 Dated 09/08/2023

Option Program : ESOP) without having obtained an approval from the SEC Office. SEC Act S.33 Settlement Committee Meeting No. 8/2023 Settlement Committee Order No. 70/2023 Dated 21/09/2023

newly issued securities in the category of warrant (Employee Stock Option Program : ESOP) without having obtained an approval from the SEC Office. SEC Act S.300 in conjunction with 33 Settlement

Capital Market Supervisory Board. Mr. Kumpol later filed the report (Form 59-2) to the SEC Office on 24 July 2023. SEC Act S.59 Settlement Committee Meeting No. 1/2024 Settlement Committee Order No. 15

Capital Market Supervisory Board. SEC Act S.56(4) Settlement Committee Meeting No. 1/2024 Settlement Committee Order No. 5/2024 Dated 30/01/2024